Investigation of the PARK10 gene in Parkinson disease

Yi Ju Li, J. Deng, G. M. Mayhew, J. W. Grimsley, X. Huo, Jeffery M Vance

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Two recent association mapping studies in Parkinson disease (PD) reported three candidate genes for the PARK10 locus: EIF2B3 as a modifier of age-at-onset of PD (min P = 0.0004) and HIVEP3 as a PD risk gene (P ≤ 0.006) (Oliveira et al. 2005); and LOC200008 (CDCP2) identified by the whole genome association (WGA) study of PD of Maraganore et al. (2005). However, evaluation of the on-line PD WGA results revealed two significant SNPs in HIVEP3 in the two datasets, Tier 1 and Tier 2, used by Maraganore et al. (P ≤ 0.008 for Tier 1 and P = 0.03 for Tier 2 dataset). Here, we revisited both the HIVEP3 and CDCP2 loci by examining 47 SNPs, mostly tagging, in an expanded PD family dataset (293 multiplex and 467 singleton families). A discordant sibpair (DSP) dataset (one DSP per family), with similar data structure as the WGA Tier 1 dataset, was also tested. We confirmed our and other previous negative findings for CDCP2. However, five significant SNPs in HIVEP3 (min P = 0.004) were observed, although the two significant HIVEP3 SNPs from the PD WGA study were not significant in our datasets. Even though the sets of significant HIVEP3 markers differ between studies, these findings strongly support HIVEP3 as a candidate for PARK10. Further testing of HIVEP3 by other groups is encouraged.

Original languageEnglish
Pages (from-to)639-647
Number of pages9
JournalAnnals of Human Genetics
Volume71
Issue number5
DOIs
StatePublished - Sep 1 2007
Externally publishedYes

Fingerprint

Parkinson Disease
Single Nucleotide Polymorphism
Genes
Genome-Wide Association Study
Genome
Datasets
Parkinson Disease 10

Keywords

  • Association Study
  • CDCP2
  • HIVEP3
  • PARK10
  • Parkinson disease

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Investigation of the PARK10 gene in Parkinson disease. / Li, Yi Ju; Deng, J.; Mayhew, G. M.; Grimsley, J. W.; Huo, X.; Vance, Jeffery M.

In: Annals of Human Genetics, Vol. 71, No. 5, 01.09.2007, p. 639-647.

Research output: Contribution to journalArticle

Li, Yi Ju ; Deng, J. ; Mayhew, G. M. ; Grimsley, J. W. ; Huo, X. ; Vance, Jeffery M. / Investigation of the PARK10 gene in Parkinson disease. In: Annals of Human Genetics. 2007 ; Vol. 71, No. 5. pp. 639-647.
@article{c604a80c3b6345008bec1b5ea2a90424,
title = "Investigation of the PARK10 gene in Parkinson disease",
abstract = "Two recent association mapping studies in Parkinson disease (PD) reported three candidate genes for the PARK10 locus: EIF2B3 as a modifier of age-at-onset of PD (min P = 0.0004) and HIVEP3 as a PD risk gene (P ≤ 0.006) (Oliveira et al. 2005); and LOC200008 (CDCP2) identified by the whole genome association (WGA) study of PD of Maraganore et al. (2005). However, evaluation of the on-line PD WGA results revealed two significant SNPs in HIVEP3 in the two datasets, Tier 1 and Tier 2, used by Maraganore et al. (P ≤ 0.008 for Tier 1 and P = 0.03 for Tier 2 dataset). Here, we revisited both the HIVEP3 and CDCP2 loci by examining 47 SNPs, mostly tagging, in an expanded PD family dataset (293 multiplex and 467 singleton families). A discordant sibpair (DSP) dataset (one DSP per family), with similar data structure as the WGA Tier 1 dataset, was also tested. We confirmed our and other previous negative findings for CDCP2. However, five significant SNPs in HIVEP3 (min P = 0.004) were observed, although the two significant HIVEP3 SNPs from the PD WGA study were not significant in our datasets. Even though the sets of significant HIVEP3 markers differ between studies, these findings strongly support HIVEP3 as a candidate for PARK10. Further testing of HIVEP3 by other groups is encouraged.",
keywords = "Association Study, CDCP2, HIVEP3, PARK10, Parkinson disease",
author = "Li, {Yi Ju} and J. Deng and Mayhew, {G. M.} and Grimsley, {J. W.} and X. Huo and Vance, {Jeffery M}",
year = "2007",
month = "9",
day = "1",
doi = "10.1111/j.1469-1809.2007.00353.x",
language = "English",
volume = "71",
pages = "639--647",
journal = "Annals of Human Genetics",
issn = "0003-4800",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Investigation of the PARK10 gene in Parkinson disease

AU - Li, Yi Ju

AU - Deng, J.

AU - Mayhew, G. M.

AU - Grimsley, J. W.

AU - Huo, X.

AU - Vance, Jeffery M

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Two recent association mapping studies in Parkinson disease (PD) reported three candidate genes for the PARK10 locus: EIF2B3 as a modifier of age-at-onset of PD (min P = 0.0004) and HIVEP3 as a PD risk gene (P ≤ 0.006) (Oliveira et al. 2005); and LOC200008 (CDCP2) identified by the whole genome association (WGA) study of PD of Maraganore et al. (2005). However, evaluation of the on-line PD WGA results revealed two significant SNPs in HIVEP3 in the two datasets, Tier 1 and Tier 2, used by Maraganore et al. (P ≤ 0.008 for Tier 1 and P = 0.03 for Tier 2 dataset). Here, we revisited both the HIVEP3 and CDCP2 loci by examining 47 SNPs, mostly tagging, in an expanded PD family dataset (293 multiplex and 467 singleton families). A discordant sibpair (DSP) dataset (one DSP per family), with similar data structure as the WGA Tier 1 dataset, was also tested. We confirmed our and other previous negative findings for CDCP2. However, five significant SNPs in HIVEP3 (min P = 0.004) were observed, although the two significant HIVEP3 SNPs from the PD WGA study were not significant in our datasets. Even though the sets of significant HIVEP3 markers differ between studies, these findings strongly support HIVEP3 as a candidate for PARK10. Further testing of HIVEP3 by other groups is encouraged.

AB - Two recent association mapping studies in Parkinson disease (PD) reported three candidate genes for the PARK10 locus: EIF2B3 as a modifier of age-at-onset of PD (min P = 0.0004) and HIVEP3 as a PD risk gene (P ≤ 0.006) (Oliveira et al. 2005); and LOC200008 (CDCP2) identified by the whole genome association (WGA) study of PD of Maraganore et al. (2005). However, evaluation of the on-line PD WGA results revealed two significant SNPs in HIVEP3 in the two datasets, Tier 1 and Tier 2, used by Maraganore et al. (P ≤ 0.008 for Tier 1 and P = 0.03 for Tier 2 dataset). Here, we revisited both the HIVEP3 and CDCP2 loci by examining 47 SNPs, mostly tagging, in an expanded PD family dataset (293 multiplex and 467 singleton families). A discordant sibpair (DSP) dataset (one DSP per family), with similar data structure as the WGA Tier 1 dataset, was also tested. We confirmed our and other previous negative findings for CDCP2. However, five significant SNPs in HIVEP3 (min P = 0.004) were observed, although the two significant HIVEP3 SNPs from the PD WGA study were not significant in our datasets. Even though the sets of significant HIVEP3 markers differ between studies, these findings strongly support HIVEP3 as a candidate for PARK10. Further testing of HIVEP3 by other groups is encouraged.

KW - Association Study

KW - CDCP2

KW - HIVEP3

KW - PARK10

KW - Parkinson disease

UR - http://www.scopus.com/inward/record.url?scp=34447622664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447622664&partnerID=8YFLogxK

U2 - 10.1111/j.1469-1809.2007.00353.x

DO - 10.1111/j.1469-1809.2007.00353.x

M3 - Article

C2 - 17388942

AN - SCOPUS:34447622664

VL - 71

SP - 639

EP - 647

JO - Annals of Human Genetics

JF - Annals of Human Genetics

SN - 0003-4800

IS - 5

ER -